A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

NCT00037674 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

434

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.